PINK1-linked parkinsonism is associated with Lewy body pathology
- PMID: 20356854
- DOI: 10.1093/brain/awq051
PINK1-linked parkinsonism is associated with Lewy body pathology
Abstract
Phosphatase and tensin homolog-induced putative kinase 1 gene mutations have been associated with autosomal recessive early-onset Parkinson's disease. To date, no neuropathological reports have been published from patients with Parkinson's disease with both phosphatase and tensin homolog-induced putative kinase 1 gene copies mutated. We analysed the coding region of phosphatase and tensin homolog-induced putative kinase 1 gene in a large Spanish family with six members with parkinsonism. The phenotype was characterized by an early-onset (mean: 31.6, standard deviation: 9.6 years, range: 14-45 years), slowly progressive levodopa-responsive parkinsonism, initial gait impairment and psychiatric symptoms. We identified two segregating pathogenic phosphatase and tensin homolog-induced putative kinase 1 mutations that were either in homozygous or heterozygous compound state in all affected family members. We found an exon 7 deletion (g.16089_16383del293; c.1252_1488del) and a novel+1U1-dependent 5' splice-site mutation in exon 7 (g.16378G>A; c.1488+1G>A). Leukocyte-derived messenger RNA analysis showed that both mutations caused exon 7 skipping and c.1488+1G>A also lead to an in-frame transcript with a 33 base-pair deletion (p.L485_R497del) resulting from activation of a 5' cryptic exon 7 splice site. Single photon emission computed tomography quantification of striatal dopamine transporter binding (123I-Ioflupane) revealed a posterior-anterior gradient similar to that of idiopathic Parkinson's disease, but there was no correlation between striatal reduced uptake and disease duration. Post-mortem neuropathological examination of an early-onset Parkinson's disease carrier of two heterozygous compound phosphatase and tensin homolog-induced putative kinase 1 mutations showed neuronal loss in the substantia nigra pars compacta, Lewy bodies and aberrant neurites in the reticular nuclei of the brainstem, substantia nigra pars compacta and Meynert nucleus, but the locus ceruleus and the amygdala were spared. This is the first neuropathological report of the brain from an early-onset phosphatase and tensin homolog-induced putative kinase 1-linked parkinsonism showing that mutated phosphatase and tensin homolog-induced putative kinase 1 protein induces Lewy body pathology. Unbalanced preservation of the locus ceruleus may well play a role in the slow evolution of motor symptoms and, probably, in the psychiatric symptoms often encountered in Parkinson's disease associated with phosphatase and tensin homolog-induced putative kinase 1 mutation.
Similar articles
-
[A-56-year-old woman with parkinsonism, whose mother had Parkinson's disease].No To Shinkei. 2001 May;53(5):495-505. No To Shinkei. 2001. PMID: 11428377 Japanese.
-
Homozygous PINK1 C-terminus mutation causing early-onset parkinsonism.Ann Neurol. 2004 Sep;56(3):427-31. doi: 10.1002/ana.20247. Ann Neurol. 2004. PMID: 15349871
-
Lewy bodies and parkinsonism in families with parkin mutations.Ann Neurol. 2001 Sep;50(3):293-300. doi: 10.1002/ana.1132. Ann Neurol. 2001. PMID: 11558785
-
The diagnosis of manganese-induced parkinsonism.Neurotoxicology. 2006 May;27(3):340-6. doi: 10.1016/j.neuro.2005.10.006. Epub 2005 Dec 1. Neurotoxicology. 2006. PMID: 16325915 Review.
-
Autosomal recessive parkinsonism.Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S4-6. doi: 10.1016/S1353-8020(11)70004-9. Parkinsonism Relat Disord. 2012. PMID: 22166450 Review.
Cited by
-
α-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson's disease.Mol Neurodegener. 2024 Oct 8;19(1):69. doi: 10.1186/s13024-024-00756-2. Mol Neurodegener. 2024. PMID: 39379975 Free PMC article.
-
Precision Dopaminergic Treatment in a Cohort of Parkinson's Disease Patients Carrying Autosomal Recessive Gene Variants: Clinical Cohort Data and a Mini Review.Neurol Int. 2024 Jul 30;16(4):833-844. doi: 10.3390/neurolint16040062. Neurol Int. 2024. PMID: 39195564 Free PMC article.
-
Mitochondrial dysfunction in Parkinson's disease - a key disease hallmark with therapeutic potential.Mol Neurodegener. 2023 Nov 11;18(1):83. doi: 10.1186/s13024-023-00676-7. Mol Neurodegener. 2023. PMID: 37951933 Free PMC article. Review.
-
Cholinergic basal forebrain system degeneration underlies postural instability/gait difficulty and attention impairment in Parkinson's disease.Eur J Neurol. 2024 Feb;31(2):e16108. doi: 10.1111/ene.16108. Epub 2023 Oct 25. Eur J Neurol. 2024. PMID: 37877681 Free PMC article.
-
Parkinson's disease relevant pathological features are manifested in male Pink1/Parkin deficient rats.Brain Behav Immun Health. 2023 Jun 19;31:100656. doi: 10.1016/j.bbih.2023.100656. eCollection 2023 Aug. Brain Behav Immun Health. 2023. PMID: 37484197 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous